Do any of the other panellists have any knowledge of that issue? No.
I'll leave it to you to look into it. Obviously, Canada's obligations to COVAX are very serious international obligations, so it might be of interest to you to find out that Canada is going to have a lot of difficulty meeting its 200-million-dose obligation. This is because of the fact that the proper due diligence wasn't done when 173 million taxpayer dollars were invested in a company that is producing a vaccine that cannot be used outside of our borders for emergency use.
Those are my questions, Mr. Chair.